| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMICUS THERAPEUTICS INC | 4,590,199 | 64,951,000 | 17.89% | ||
| 2 | SORRENTO THERAPEUTICS INC COM NEW | 2,186,520 | 38,526,000 | 10.61% | ||
| 3 | MIRATI THERAPEUTICS INC COM | 1,000,000 | 31,470,000 | 8.67% | ||
| 4 | Lion Biotechnologies | 2,923,065 | 26,805,000 | 7.38% | ||
| 5 | ONCOTHYREON INC COM N/C EFF 6/ | 5,617,003 | 21,008,000 | 5.79% | ||
| 6 | ACADIA PHARMACEUTICALS INC COM | 495,000 | 20,731,000 | 5.71% | ||
| 7 | AGENUS INC | 2,199,137 | 18,979,000 | 5.23% | ||
| 8 | VANDA PHARMACEUTICALS INC COM | 1,438,693 | 18,257,000 | 5.03% | ||
| 9 | LA JOLLA PHARMACEUTICAL CO | 611,999 | 15,000,000 | 4.13% | ||
| 10 | IGI LABS INC | 1,753,682 | 11,048,000 | 3.04% | ||
| 11 | CELLDEX THERAPEUTICS INC NEW | 352,350 | 8,886,000 | 2.45% | ||
| 12 | VERACYTE INC | 758,497 | 8,450,000 | 2.33% | ||
| 13 | PERNIX THERAPEUTICS HLDGS IN | 1,250,167 | 7,401,000 | 2.04% | ||
| 14 | Innocoll | 497,422 | 7,277,000 | 2.00% | ||
| 15 | AXOVANT SCIENCES LTD | 340,000 | 6,929,000 | 1.91% | ||
| 16 | TONIX PHARMACEUTICALS HLD | 755,300 | 6,775,000 | 1.87% | ||
| 17 | NEURODERM LTD | 371,111 | 5,697,000 | 1.57% | ||
| 18 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 267,747 | 5,674,000 | 1.56% | ||
| 19 | BELLICUM PHARMACEUTICALS INC COM | 262,515 | 5,584,000 | 1.54% | ||
| 20 | Receptos Inc | 26,500 | 5,036,000 | 1.39% | ||
| 21 | HERON THERAPEUTICS INC | 150,000 | 4,674,000 | 1.29% | ||
| 22 | ALLIQUA BIOMEDICAL INC | 800,000 | 4,216,000 | 1.16% | ||
| 23 | VERICEL CORP | 1,083,486 | 3,868,000 | 1.07% | ||
| 24 | ADAPTIMMUNE THERAPEUTICS PLC | 183,900 | 3,371,000 | 0.93% | ||
| 25 | FORTRESS BIOTECH INC | 929,531 | 3,123,000 | 0.86% | ||
| 26 | TRILLIUM THERAPEUTICS INC | 94,400 | 2,060,000 | 0.57% | ||
| 27 | Heat Biologics Inc Com | 335,102 | 2,011,000 | 0.55% | ||
| 28 | BIOGEN INC | 4,500 | 1,818,000 | 0.50% | ||
| 29 | TARGACEPT INC | 587,315 | 1,639,000 | 0.45% | ||
| 30 | CELLECTIS S A | 30,000 | 1,082,000 | 0.30% | ||
| 31 | SPDR S&P BIOTECH ETF | 350,000 | 770,000 | 0.21% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049536, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
